A pharmaceutical firm has opened a new manufacturing and development facility in Roscommon.

The building for Jazz Pharmaceuticals is situated on a 17-acre site in Monksland.

It is the first directly owned, managed and operated manufacturing facility built by Jazz. The company has invested approximately €50 million in the development, which was supported by IDA Ireland.

Chairman and Chief Executive of Jazz, Bruce Cozadd, said: "This new manufacturing and development facility is an investment in Ireland and also an investment in our growing global infrastructure, which will enable us to more closely oversee and control the process of bringing high quality products to patients. It is particularly meaningful for us to open it in Ireland, close to our global corporate headquarters in Dublin. We were encouraged to come to Roscommon because of the excellent track record of this community in supporting the pharmaceutical industry and the pool of local talent available. We would like to acknowledge the local community, the Roscommon Country Council and IDA Ireland for their continued support and collaboration, and note the remarkable pro-business environment in Ireland that facilitates investments like this one."

-- Advertisement --

(CD/LM)